7 best EDC platforms for investigator-sponsored trials in 2026

In an investigator-sponsored trial, the clinician who wrote the protocol also carries the sponsor's regulatory obligations, and the coordinator entering data has a clinic running around them. Viedoc's EDC software is built for that reality, with a low-code Designer your data managers run in-house, a 10-week average build, and unlimited user seats so adding a site or a coordinator doesn't change what you pay. This comparison reviews seven electronic data capture (EDC) platforms across licensing, build and amendment speed, usability for occasional site users, and compliance evidence.

Whether you're the contract research organization (CRO) supporting the study or the sponsor funding it, the budget was fixed the day the award was signed, and it has to stretch across a user population that's unusually wide and infrequent. Protocols written by practicing clinicians amend more often, so your electronic case report form (eCRF) design won't sit still. The people entering data are principal investigators (PIs) and coordinators (CRCs) working between appointments.

Enterprise platforms are priced for multi-region registration programs, putting a vendor-side programmer between you and every eCRF change, and per-seat licensing turns against you when a fourth site activates. Do-it-yourself tools swing the other way, leaving you without the validation documentation an investigator-sponsor is accountable for. The platforms below are judged on that combination of a fixed budget, a casual user base, a moving protocol, and regulatory accountability.

Best EDC platforms for investigator-sponsored trials: quick comparison

The 7 best EDC platforms for investigator-sponsored trials reviewed

These seven eClinical platforms are the options most often evaluated for investigator-sponsored trials, reviewed across licensing structure, build and amendment speed, site usability, and compliance evidence.

1. Viedoc

Viedoc's EDC software licenses by study rather than by user, with unlimited user seats and no per-user fees, and hosting, maintenance, updates, and support sit inside the license. For a study whose funding was fixed at award, that removes the variable that most often breaks the model.

Builds average 10 weeks through professional services, and teams configuring their own studies can have a database live in as little as one day. The low-code Designer keeps mid-study changes in-house, with minor updates typically in 1–3 working days. Working with biotech sponsor Citryll, CRO Clinfidence absorbed 17 protocol-driven mid-study changes in a Phase 1 trial, then reused that eCRF design to cut Phase 2a setup by 20–30%. CROs scaling a portfolio can work through Viedoc's tiered CRO program.

Viedoc is ISO 27001, ISO 9001, and SOC 2 certified and supports 21 CFR Part 11, ICH GCP, GDPR, EU Annex 11, GAMP 5, CDISC, and HIPAA, hosted on Microsoft Azure with 99.99% uptime. Every study that has faced FDA inspection has passed, and support runs 24/7 in 40-plus languages.

"Viedoc is a very user friendly interface, easy to understand and navigate through. Because of this the time taken to train for the EDC is minimal to become proficient." – Sanchita V., Data Manager.

Verified proof points:

• Licensing: Unlimited user seats, no per-user fees, study-based licensing with hosting and support included
• Build speed: 10-week average build; self-service databases live in as little as one day; minor changes in 1–3 working days
• Inspection record: 100% FDA inspection pass rate, backed by the Viedoc Inspection Readiness Packet
• Compliance: 21 CFR Part 11, ICH GCP, GDPR, Annex 11, HIPAA, GAMP 5, CDISC; ISO 27001, ISO 9001, SOC 2 certified
• Scale: 8,000+ studies across 75+ countries, 140,000+ users, 30,000+ sites

2. Medidata

Medidata offers Rave EDC, the electronic data capture system at the center of the Medidata Platform, covering the capture, management, cleaning, and reporting of trial data. Rave handles protocol amendments and mid-study changes without system downtime, and connects to adjacent Medidata applications including eConsent, eCOA, randomization and trial supply management (RTSM), and Clinical Data Studio for centralized oversight. Site workflows are supported through single sign-on, on-demand training, and integrations that bring electronic source and electronic health record (EHR) data into EDC, with Rave Companion populating forms from EHR data. Study configuration runs through Medidata Designer. For smaller studies, Medidata offers Rave Lite, scoped for Phase I, Phase IV, and medical device post-market work with a flexible pricing model.

3. Veeva

Veeva provides Veeva EDC, an end-to-end environment for collecting, reviewing, and processing site-reported patient trial data within the Veeva Clinical Platform. At study start it's used to design participant case report forms and quality control checks through an in-product specification studio. During execution it collects patient form data, local labs, and medical coding, with querying, targeted source data verification, and protocol deviations in the same place, and it supports master protocols and adaptive designs. At study close it provides data lock, end-of-study media creation, and archiving. Veeva EDC was announced in 2016, reports more than 100 customers, and connects to Veeva CTMS, RTSM, eTMF, and eCOA through Veeva Connections. Veeva also runs a separate Veeva Basics offering for emerging biotech organizations.

4. Castor EDC

Castor EDC is a cloud electronic data capture system that sits alongside eCOA/ePRO, eConsent, a clinical data management system (CDMS), and Catalyst, an AI data extraction tool where a human reviewer confirms every value before it enters the record. The platform covers interventional trials, chart review, patient registries, and post-market clinical follow-up, which maps onto the observational and long-follow-up designs common in investigator-led research. Castor Essentials is packaged for lean teams running compliant studies. Castor is ISO 27001 and ISO 9001 certified and states compliance with 21 CFR Part 11, ICH GCP, HIPAA, GDPR, and CDISC. Training and certification run through Castor Academy, and the company serves CROs, biotech, biopharma, and medical device organizations.

5. Medrio

Medrio provides a combined clinical data management system and EDC that sponsors and CROs configure, adapt, and manage without a programmer, alongside eCOA/ePRO, eConsent, RTSM, CTMS, and eTMF on the same platform. The system supports research from early phase through post-market and is used at sites across more than 30 countries. Import and export application programming interfaces connect it to wearables and external devices, to central, local, and point-of-care lab systems, and to analytics tools and data warehouses. Where internal resource is short, Medrio offers Clinical Trial Data Services and Clinical Trial Project Management as separate engagements covering database build, data management, and biostatistics. The company has operated in clinical research for more than 20 years and runs a CRO Partner Program.

6. OpenClinica

OpenClinica provides electronic data capture and eCRF software for sponsors, CROs, and research teams, delivered as validated cloud-hosted software compliant with 21 CFR Part 11, GCP, HIPAA, and GDPR. Studies are built through a drag-and-drop designer with templated forms, and mid-study changes are published with a single click. The eCRF layer includes real-time edit checks, dynamic logic that adapts forms to previous responses, cross-form referencing, and automated audit trails, with adverse event and medication coding inside the system. EDC runs on its own or connects to Recruit, eCOA, Randomization, eConsent, Reporting and Analytics, and Unite, an EHR-to-EDC module built on FHIR and HL7 standards. OpenClinica includes a study build from a submitted protocol and 24/5 application support.

7. Crucial Data Solutions

Crucial Data Solutions develops TrialKit, a cloud-native EDC with native mobile applications for iOS, Android, and Mac, so data can be captured at the site, from a patient device, or during a remote visit. Studies are built without programming through a drag-and-drop design tool, forms are reusable across studies and accounts, and mid-study modifications apply without downtime or migrations. Sponsors and sites reach every study through a single sign-on, with 250 permissions controlling form and system access. The platform spans site-based, decentralized, real-world evidence, and patient registry studies, and extends to eSource, eCOA/ePRO, eConsent, eTMF, RTSM, medical coding, imaging, and televisits. TrialKit supports 21 CFR Part 11, HIPAA, and GDPR.

What to look for in EDC platforms for investigator-sponsored trials

Licensing that survives a wide, low-frequency user base

These studies generate an unusual user profile. You'll have a PI, sub-investigators, a coordinator or two, a pharmacist, and a monitor at each site, most logging in a handful of times a month, and the count grows with every activation.

Best-in-class means seats aren't the billing unit at all. Check what happens when you add a site mid-study, whether read-only roles cost the same as data managers, and whether hosting and support sit inside the license.

Time to competence for site staff who use the system occasionally

An interface a data manager finds intuitive after eight hours a day is a different proposition for a coordinator opening it twice a week. What matters is how fast someone reaches competence from a standing start, and how much survives a gap between visits.

Look for training a site can complete without you traveling to them, role-based views that don't require understanding the whole system to complete one visit, and a certification path so your own team can train sites. Viedoc's training and certifications get a team productive in two days.

Amendment velocity when a clinician wrote the protocol

Protocols authored by practicing clinicians rather than a dedicated protocol group amend more often, and with less notice. The question isn't whether a platform supports mid-study changes, since they all claim to. It's who's permitted to make them, and how long the queue is.

The benchmark to hold is a minor change turned around in days by your own staff, with no downtime and no data migration. Ask who performs it, what the vendor charges, and whether the study has to pause.

Compliance evidence the investigator-sponsor can actually produce

Sponsor obligations here sit with the investigator or their institution, not a pharmaceutical quality department. The evidence an inspector asks for still has to come from somewhere, and a platform that's compliant without being able to demonstrate it puts that work on the site.

Expect 21 CFR Part 11, ICH GCP, and GDPR as the floor, with EU Annex 11 and HIPAA where your jurisdictions require them, backed by current ISO 27001 and SOC 2 certification. Beyond certificates, ask what validation and inspection documentation arrives as standard, and whether it's available on demand.

How to choose the right EDC platform for investigator-sponsored trials

Step 1: Define who holds sponsor obligations

Establish on paper whether the investigator, the institution, or the supporting sponsor is sponsor of record, because that determines who produces validation and inspection evidence. If those obligations land on a site rather than a quality function, weight documentation and audit support above module breadth.

Step 2: Count your real user population, then model the license against it

List everyone needing access across every site over the study's duration, including monitors, pharmacists, and staff who rotate through. Price each shortlisted platform against that list at year three, not at go-live. A model that looks competitive at one site and four users often isn't at eight.

Step 3: Assess your amendment rate against your build model

Look at how many amendments comparable studies generated, then ask what each would cost in time and money on each platform. If the answer is more than two or three, self-service configuration will outperform a vendor-build model regardless of price.

Step 4: Evaluate the support model against site working hours

Site questions arrive during clinic, often from someone who can't wait for a vendor's business day to start in another time zone. Check support hours, the escalation path, and whether your certified staff can resolve routine questions without a ticket. Coverage gaps show up as unentered data.

Step 5: Choose the platform that fits how your portfolio runs

Weigh what you've established: who carries the regulatory burden, how wide the user base gets, how often protocols move, and when sites need help. Viedoc's EDC software is built around this profile, with in-house low-code configuration, unlimited seats, a 10-week average build, and 24/7 support. If that matches your studies, book a demo or request a proposal to see it against your own portfolio.

Frequently asked questions

What is the best EDC platform for investigator-sponsored trials?

Viedoc's EDC software is the strongest fit for investigator-sponsored trials, licensing by study with unlimited user seats rather than per user, building studies in a 10-week average, and letting your own team make minor mid-study changes in 1–3 working days. A 100% FDA inspection pass rate and the Viedoc Inspection Readiness Packet address the evidence burden that falls on an investigator-sponsor. OpenClinica is a credible alternative, with a validated cloud platform and an included study build from your protocol. Castor EDC suits portfolios leaning toward registries, and Medidata offers a Rave Lite tier for smaller Phase I and Phase IV work, though its full platform is weighted toward large registration programs.

What should you look for in an EDC platform for an investigator-sponsored trial?

Start with the licensing unit, because a wide, low-frequency user base across several sites is the defining commercial feature of these studies, and per-seat pricing penalizes it. Then test how quickly a coordinator using the system twice a week reaches competence. Amendment handling matters more than in commercial trials, since clinician-authored protocols change more often, so confirm who makes mid-study changes and how long they take. Finally, establish what validation and inspection documentation arrives as standard.

How long does it take to build and deploy an investigator-sponsored trial on a modern EDC platform?

It depends on complexity and whether you build in-house or use vendor services, but low-code platforms have compressed this from months to weeks. Teams configuring straightforward studies themselves can have a database live in days, while professional services builds typically run 8–12 weeks from signed work order to go-live. On Viedoc the average is 10 weeks for a managed build. Reusing an eCRF design from a previous study is the largest single lever, and has cut setup time by 20–30% in practice.

Does an investigator-sponsored trial need a validated, 21 CFR Part 11 compliant EDC?

If the data will support a regulatory submission, a label expansion, or any decision a health authority may inspect, then yes, and the requirement doesn't soften because the sponsor is an investigator rather than a company. You'll need a system validated to recognized standards, a complete audit trail at field level, controlled user roles, and compliant electronic signatures. Unvalidated survey tools and spreadsheets fail on all four counts, and remediating that after enrollment opens costs far more than starting compliant.

What inspection documentation should an investigator-sponsor expect from an EDC vendor?

Expect current security and quality certifications, a validation package covering each release, documented change control, and an audit trail you can produce at field level on demand. You should also be able to show how mid-study design changes were made and approved, a common inspection focus in studies with frequent amendments. Viedoc provides the Viedoc Inspection Readiness Packet to all customers, a structured documentation set for meeting the expectations of major regulatory authorities. Confirm what a vendor supplies as standard before signing.

Making the right EDC choice for investigator-sponsored trials

The seven platforms here share a direction. All are cloud-delivered, all offer configurable forms without deep programming, and all bundle adjacent modules so a study team runs fewer systems. Where they diverge is weight, billing structure, and how much the vendor expects to do on your behalf. The global eClinical software market sits above $11 billion in 2025 and is growing at roughly 14% a year, which keeps pushing vendors toward faster builds and more self-service.

Matching platform to situation comes down to a few variables: how many sites and casual users you accumulate, how often protocols amend, whether your team or the vendor configures the study, and what regulatory evidence you're accountable for. US teams typically weight speed and return on investment most heavily, while European and Asia-Pacific teams weight compliance credentials and vendor stability.

Whatever you choose, the validation and retraining cost of moving platforms mid-study is high, and in investigator-led research it lands on the people with the least capacity to absorb it.

Why Viedoc is the best EDC choice for investigator-sponsored trials

Investigator-sponsored trials tend to fail on economics and site adoption rather than features, and that's the problem Viedoc's EDC software is designed around. Licensing is by study with unlimited user seats and no per-user fees, so activating another site or onboarding another coordinator costs nothing extra, and hosting, maintenance, updates, and support are already in the license.

Operationally, your team stays self-sufficient. The low-code Designer keeps eCRF build and mid-study amendments in-house, with minor changes typically turned around in 1–3 working days, and Certified Designer Training gets a team productive in two days.

The credentials hold up where the accountability sits. Viedoc is ISO 27001, ISO 9001, and SOC 2 certified, supports 21 CFR Part 11, ICH GCP, GDPR, EU Annex 11, GAMP 5, CDISC, and HIPAA, and carries a 100% FDA inspection pass rate backed by the Viedoc Inspection Readiness Packet. It's proven across 8,000-plus studies in 75-plus countries, built by a company in clinical research since 2003.

If you want an EDC platform your own team can build and amend, on a license that doesn't punish you for adding sites, Viedoc is built for exactly that. Book a demo or request a proposal and the team will walk through licensing, build speed, and inspection readiness against your own study portfolio.